Interestingly, severely disrupted function of the CP in humans has been associated with pathological progressions in AD, frontotemporal dementia, Huntington’s disease, and severe COVID19 (Kant et al. 2018; Stopa et al. 2018; Tadayon et al. 2020; Yang et al. 2021). This evidence concerns the gene CP and Alzheimer disease.